
You’re visiting the UK site but it looks like your in the USA, would you like to be redirected for more relevant content?
In July 2026, the Office for Equality and Opportunity launched a 15-week consultation on the most significant overhaul of the UK’s equal pay framework in decades. For life sciences employers, particularly those competing hard for talent, the proposals go well beyond a compliance footnote. Pay transparency in job adverts, tougher audit requirements and a new enforcement unit would all touch how roles are advertised, benchmarked and offered.
The consultation closes on 27 October 2026. Nothing is law yet, and the government has been explicit that any changes will follow an extended, staggered implementation period. But the direction of travel is clear, and hiring managers who start adjusting their practices now will be far better placed than those who wait for the legislation to land.
The single change most likely to affect day-to-day recruitment is a proposed statutory requirement for employers to publish pay information in job adverts, or provide it in writing to candidates before interview where there is no advert. The government has not yet settled on how much detail this would involve; a specific salary, a benchmarked range and additional detail such as bonus structures or collective bargaining terms are all still on the table.
For hiring managers, the practical implications include:
The government notes that many employers, including a large share of those in life sciences, already publish pay ranges voluntarily. Organisations already doing this have a head start; those relying on “competitive salary” wording do not.
The consultation proposes tightening the circumstances in which an Employment Tribunal must order an equal pay audit after a breach is found, narrowing the current exceptions significantly. It also proposes that tribunals be required to order the implementation of a non-discriminatory job evaluation scheme alongside any audit, where one is not already in place.
In practice, this raises the stakes of not having a structured, consistent approach to grading and pay decisions. Life sciences employers with genuinely comparable roles across R&D, medical affairs, commercial and market access functions should be able to show that pay differences are explained by defensible, non-discriminatory factors, not informal precedent.
At present, enforcement rests almost entirely on individual claimants bringing tribunal cases, a slow and adversarial process for everyone involved. The consultation proposes a new Equal Pay Regulatory and Enforcement Unit, potentially housed within the Equality and Human Rights Commission or the Fair Work Agency, with stronger powers to:
This represents a shift from reactive litigation toward proactive scrutiny. Employers may find themselves asked to evidence their pay practices without a prior tribunal claim triggering it.
A second phase of reform, to follow once the current system is improved, proposes broadly “levelling up” protections against pay discrimination on the grounds of race and disability so they more closely match the existing sex-based equal pay scheme. This includes exploring whether tribunals should be able to modify discriminatory contract terms directly, and whether equal pay audits and job evaluation requirements should extend to race and disability cases.
For life sciences employers with global or matrixed structures, where pay benchmarking sometimes varies significantly by function, geography or historic acquisition, this is worth watching closely. It signals that pay equity analysis focused solely on gender is unlikely to be sufficient in the medium term.
The consultation also proposes a new duty on all parties in an outsourcing arrangement, principal, intermediaries and service providers, to take “all reasonable steps” to uphold pay equality. This is relevant to life sciences organisations that rely on outsourced clinical, manufacturing or field-based teams, where pay parity between directly employed and outsourced staff doing equivalent work has historically been difficult to challenge.
None of this needs to be actioned overnight, and the government has been clear that employers will have time to prepare. But there is real value in getting ahead of the direction of travel:
It’s worth stressing that these are proposals under consultation, not confirmed law. The government has committed to a phased approach, fixing enforcement and transparency first, before broadening protections in a second phase, with an extended implementation period for any measures that are eventually confirmed. Employers have time to prepare, but the scale of the proposed reform means the organisations that start reviewing their pay practices now will be in a far stronger position than those who wait.
Established in 2006 by founders who began their careers in pharma, sector expertise has always been at the heart of Carrot Recruitment’s identity and success. Today, we operate globally, connecting exceptional professionals with businesses driving innovation in life sciences.
The majority of our assignments span the USA, the UK, and Europe with a focus on mid-to-senior level appointments. Notably, much of our work is now conducted through exclusive partnerships, enabling us to provide a highly tailored, high-quality service that drives long-term talent retention and business success.
